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Caspases are responsible for the execution of programmed cell death (apoptosis) and must undergo proteolytic
activation, in response to apoptotic stimuli, to function. The mechanism of initiator caspase activation has been
generalized by the induced proximity model, which is thought to drive dimerization-mediated activation of caspases.
The initiator caspase, caspase-9, exists predominantly as a monomer in solution. To examine the induced proximity
model, we engineered a constitutively dimeric caspase-9 by relieving steric hindrance at the dimer interface. Crystal
structure of the engineered caspase-9 closely resembles that of the wild-type (WT) caspase-9, including all relevant
structural details and the asymmetric nature of two monomers. Compared to the WT caspase-9, this engineered dimer
exhibits a higher level of catalytic activity in vitro and induces more efficient cell death when expressed. However, the
catalytic activity of the dimeric caspase-9 is only a small fraction of that for the Apaf-1-activated caspase-9.
Furthermore, in contrast to the WT caspase-9, the activity of the dimeric caspase-9 can no longer be significantly
enhanced in an Apaf-1-dependent manner. These findings suggest that dimerization of caspase-9 may be qualitatively
different from its activation by Apaf-1, and in conjunction with other evidence, posit an induced conformation model
for the activation of initiator caspases.
Citation: Chao Y, Shiozaki EN, Srinivasula SM, Rigotti DJ, Fairman R, et al. (2005) Engineering a dimeric caspase-9: A re-evaluation of the induced proximity model for caspase
activation. PLoS Biol 3(6): e183.
Introduction
Apoptosis plays a central role in animal development and
tissue homeostasis. The essential machinery responsible for
the execution of apoptosis is the caspases, a family of closely
related cysteine proteases [1–6]. Caspases comprise two
classes: the initiator caspases, such as caspase-8 and -9, and
the effector caspases, such as caspases-3 and -7. Due to their
deleterious roles, all caspases are synthesized as relatively
inactive zymogens in the cell and, in response to apoptotic
stimuli, undergo proteolytic activation. The activation of
effector caspases is performed by the initiator caspases. The
autoactivation of the initiator caspases is facilitated by other
auxiliary factors. For example, the autoactivation of caspase-9
is mediated by the assembly of a heptameric complex
involving Apaf-1 and cytochrome c, dubbed the apoptosome
[7–9]. Once activated, caspase-9 cleaves and activates cas-
pases-3 and -7.
The molecular mechanism for the activation of the effector
caspases has been elucidated [6]. The caspase zymogen, such
as procaspase-7, exists as a homodimer in solution but
exhibits poor catalytic activity because its active sites exist in
an unproductive conformation. The activation cleavage of
procaspase-7 allows the relocation of a surface loop from one
monomer to critically support the active site of the adjacent
monomer, hence allowing catalysis to proceed [10,11].
In contrast, the mechanism for the activation of the
initiator caspases, which generally involves the formation of
an oligomeric complex [9], has remained elusive [12]. The
prevailing hypothesis has been the ‘‘induced proximity’’
model, which summarized a set of elegant experiments [13–
17] to state that caspase zymogens are autoprocessed once
they are brought into proximity with each other [18].
However, this initial explanation of the induced proximity
model contained little mechanistic information until it was
enhanced by the proposition that the oligomeric complex
(such as the apoptosome) serves to activate the monomeric
initiator caspases through induced dimerization via their
intrinsic dimerization interface [19–21]. Supporting this
hypothesis, caspase-9 exists predominantly as a monomer in
solution and exhibits a basal level of catalytic activity [19,22].
Induced proximity, interpreted as dimerization-driven acti-
vation of caspases, is perceived as a dominant model of
initiator caspase activation [19–21,23].
Despite its popularity, the notion of dimerization-driven
activation of initiator caspases is at odds with some well-
known facts. For example, if the activation of the initiator
caspases requires merely dimerization, why would the
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apoptosome exhibit a 7-fold symmetry? Along this line, the
activation of caspase-8 requires the assembly of a multi-
component death-inducing signaling complex, which has a 3-
fold symmetry.
The induced proximity model states that the dimerization
of caspase-9, via its intrinsic dimerization interface, is the
central and only step in its activation, and the assembly of the
apoptosome serves merely to facilitate the dimerization of
caspase-9 [19,20,23]. Thus, caspase-9 in its dimeric form is
expected to exhibit the same catalytic activity as caspase-9
when it is activated by the apoptosome. An essential experi-
ment in assessing the correctness of this prediction is to
directly compare the catalytic activity of the dimeric caspase-
9 with that of the apoptosome-activated caspase-9. Unfortu-
nately, the wild-type (WT) caspase-9 dimer defies isolation,
because it does not represent a stable state in solution [22].
The only approach is to engineer a constitutive caspase-9
homodimer that will dimerize via its intrinsic dimerization
interface.
In this report, we revisit the induced proximity model
through the engineering of a constitutively dimeric caspase-9.
We demonstrate that, despite the fact that this dimer variant
exhibits a higher level of catalytic activity in vitro and induces
more efficient cell death than the WT caspase-9, it is
qualitatively different from the Apaf-1-activated caspase-9.
Importantly, the structure of the engineered caspase-9 closely
resembles that of the WT caspase-9, including all relevant
structural details and the asymmetric nature of the two
monomers. Our data, in conjunction with other evidence,
suggest a refined model of the induced proximity hypothesis.
At the center of this model is an induced conformation of the
active site, hence the name induced conformation model.
Results
Rationale for the Design of a Dimeric Caspase-9
While all members of the caspase family share a similar
overall structure, small differences in their primary sequences
lead to their individuality [1,4]. An effector caspase, such as
caspase-3, exists exclusively as a stable homodimer in
solution. In contrast, biochemical and structural analyses
revealed that dimerization of the initiator caspase-9, although
possible, was energetically unfavorable [1,19,22]. To facilitate
the design of a constitutively dimeric caspase-9, we examined
the dimerization interface of several representative caspases.
In caspase-3, the dimerization interface is mediated
primarily by two b-strands (b6 and b69), one from each
monomer (Figure 1A). Together, 63% of the buried surface
area at the dimeric interface is contributed by these two
centrally located b-strands and their immediate flanking
residues. Consistent with a critical role in dimerization,
residues on these two b-strands exhibit relatively low
temperature factors. Importantly, sequence alignment among
four representative caspases revealed an extremely varied
section of five consecutive amino acids on strand b6, flanked
on either side by stretches of conserved residues (Figure 1B).
For example, the five residues Cys264-Ile-Val-Ser-Met268 in
caspase-3 are replaced by Gly402-Cys-Phe-Asn-Phe406 in
caspase-9, while five of the eight flanking residues are
invariant between these two caspases. Compared to caspase-
3, caspases-6 and -7, also known to exist as homodimers in
solution, contain similarly conserved residues on the b6
strand (Figure 1B). This observation further supports a
critical role of the b6 strand in dimerization and suggests a
conserved pattern required for dimerization. In agreement
with this analysis, previous structural investigation showed
that Phe404 and Phe4049, one of the five residues on strands b6
and b69, respectively, appear to impede the dimerization of
caspase-9 by way of their incompatible side-chain config-
uration at the interface (Figure 1A) [19].
In addition to strand b6, two surface loops also appear to
contribute to the dimerization of both caspases-3 and -9.
Although residues from these surface loops also differ
between the two caspases, they are involved in a coordinated
change. For example, Asp231 on chain A of a caspase-3 dimer
hydrogen bonds to His234 on chain B, while the same
hydrogen bond is spatially conserved between Lys410 on
chain A and Ser382 on chain B in caspase-9 [19]. Thus we
concluded that these surface loops in caspase-9 play a similar
role as in caspase-3 and are unlikely to be the impediment for
the dimerization of caspase-9.
The Engineered Caspase-9: A Constitutive Homodimer
The drastic difference in sequences as well as in bonding
arrangements of strand b6 between caspases-3 and -9 led us
to conclude that the higher propensity of caspase-3 to
dimerize than caspase-9 is a direct result of the sequence
variation in strand b6. To generate a potentially dimeric
caspase-9, we replaced five residues in the b6 strand of
caspase-9 (Gly402-Cys-Phe-Asn-Phe406) with those in caspase-3
(Cys264-Ile-Val-Ser-Met268), using standard mutagenesis meth-
ods. This engineered caspase-9 was overexpressed in bacteria
and purified to homogeneity (see Materials and Methods for
details).
First, we compared the oligomeric states of the engineered
and WT caspase-9 using size exclusion chromatography. The
elution volume for the WT protein (residues 1–416), which
contains a prodomain and a flexible linker segment between
the prodomain and the protease domain, corresponds to a
molecular mass of approximately 60 kDa (Figure 2), slightly
larger than that expected for a monomer (approximately 46
kilodaltons [kDa]). This is consistent with the fact that the
prodomain and the flexible linker segment of caspase-9 may
increase its hydrodynamic radius in solution. In contrast, the
elution volume of the engineered caspase-9 (residues 1–416)
corresponds to a molecular mass of about 120 kDa (Figure 2),
approximately twice that observed for the WT protein. To
better correlate elution volume with molecular mass, WT and
engineered proteins were also prepared in which the
prodomain and the flexible linker were removed (D139). In
this case, the elution volumes for the WT and engineered
caspase-9 (D139, residues 140–416) corresponded to 30 kDa
and 60 kDa, respectively, consistent with a monomer and a
dimer of caspase-9 (D139) (unpublished data).
To precisely determine the molecular mass of the
engineered caspase-9, we performed sedimentation equili-
brium experiments using analytical ultracentrifugation.
Analysis of the data for the engineered caspase-9 (residues
1–416), at three rotor speeds, reveals a molecular mass of
91,030 6 2,100 daltons (Da) (Table 1). This is very close to the
expected molecular weight of a homodimer (94,610 Da). In
contrast, the WT caspase-9 exhibited a molecular mass of
50,550 6 2,550 Da (Table 1), slightly larger than that of a
monomer (47,357 Da). Data fitting indicated that the slightly
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larger molecular mass is not due to a monomer-dimer
equilibrium. Rather, it is likely due to a small degree of
higher-order nonspecific association among the monomers.
Similarly, analysis of the data for the WT and engineered
caspase-9 (D139) reveals molecular masses of 36,450 6 3,300
and 61,490 6 2,350 Da, respectively. These values are close to
the predicted molecular masses of monomeric (31,426 Da)
and dimeric (62,746 Da) caspase-9 (D139).
Thus, results derived from gel filtration and analytical
ultracentrifugation analysis unequivocally show that our
engineered caspase-9, which contains a five-residue replace-
ment at the dimeric interface, exists predominantly as a
homodimer in solution. For the sake of discussion, the
engineered caspase-9 is hereafter referred to as the dimeric
caspase-9.
Structure of the Dimeric Caspase-9
One important assumption from our engineering effort is
that the replacement of five amino acids in strand b6 would
not significantly alter the local structure of the dimeric
caspase-9 surrounding strand b6, as compared to the WT
caspase-9. Although this assumption is supported by the
highly conserved nature of caspase structures, it must be
proved experimentally. To obtain a structure of the dimeric
caspase-9, we mounted a vigorous crystallization effort.
However, the enhanced enzymatic activity (see below) of the
dimeric caspase-9 led to time-dependent degradation of the
protein under a variety of conditions (unpublished data) that
impeded crystallization. To solve this problem, we mutated
the catalytic residue Cys287 to Ser and were able to crystallize
this catalytically inactive form of the dimeric caspase-9. The
structure was determined at 2.8 A˚ (Figure 3A and Table 2).
Figure 1. The b6 Strand Is the Major Determinant for the Dimerization of Caspases
(A) Comparison of the dimerization interfaces of caspase-3 and caspase-9. Caspases-3 and -9 exist primarily as a dimer and a monomer,
respectively, in solution. However, inhibitor-bound caspase-9 was crystallized in its dimeric form [19]. The overall structures of caspases-3 and -9
are similar. A close-up view of the dimerization interfaces reveals sharp variation of residues on the b6 strand between caspase-3 and -9, which
likely contributes to their different propensity for dimer formation. For caspase-9, Phe404 on strand b6 appears to impede dimerization as it
sterically clashes with Phe4049 of the adjacent monomer [19].
(B) A sequence alignment of the residues on and surrounding the strand b6 in four representative caspases. Similar to caspase-3, caspases-6 and -
7 also exist as homodimers in solution. Residues on b6 are highlighted in blue and orange for the monomeric and dimeric caspases, respectively.
Note that the variation of residues on b6 strand appears to correlate with the propensity for dimerization.
DOI: 10.1371/journal.pbio.0030183.g001
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This structure offers a number of interesting findings, all of
which support the assumption that the five-residue replace-
ment does not alter the local structure of caspase-9
surrounding strand b6. First, the dimeric caspase-9 exists as
an asymmetric homodimer in an identical manner to the WT
caspase-9 [19]. In fact, the dimeric caspase-9 was crystallized
in the same space group as the WT caspase-9 with essentially
identical unit cell parameters. Just like the WT caspase-9,
there are two molecules of the dimeric caspase-9 in each
asymmetric unit, and the crystal packing interaction is
identical. This observation also indicates that Phe404 is not
a contributing reason for the observed asymmetry in caspase-
9 as previously suggested [19], as Phe404 is replaced by Val in
the dimeric caspase-9. Rather, the asymmetry appears to be
an intrinsic property of caspase-9 determined by other
sequence elements. It should be pointed out that, in theory,
crystal-packing interactions could be the reason for both WT
and dimeric caspase-9 to adopt a similar conformation in the
crystals. However, such packing interactions are usually
extremely weak compared to the forces that govern protein
stability and are generally unable to perturb any well-formed
structural elements.
Second, despite being an inactive zymogen, the dimeric
caspase-9 is nearly identical to the WT caspase-9 for the core
structural elements, with a root mean square deviation
(RMSD) of 0.4 A˚ over 380 aligned Ca atoms (Figure 3B).
The only significant structural difference occurs at the
solvent-exposed surface loops L2, L4, L29, and L49 (Figure
3B). These differences reflect the active and inactive nature of
the WT caspase-9 and dimeric caspase-9, respectively. As is
the case for all other active caspases [1], the conformation of
these four loops in the inhibitor-bound dimeric caspase-9 is
expected to be identical to that of the inhibitor-bound WT
caspase-9.
Third and most importantly, the conformation of the
amino acids surrounding strands b6 and b69 in the dimeric
caspase-9 remains extremely similar or identical to that in the
WT caspase-9 (Figure 3C). For example, all amino acids in the
neighboring strands b5 and b59 in the dimeric caspase-9
retain the same side chain rotamer conformation as in the
WT caspase-9 (Figure 3C). There is no significant conforma-
tional change in any part of the local structure. Thus we
conclude that the impact of the five-residue replacement is
naturally absorbed without any significant structural rear-
rangement, and that the dimeric caspase-9 faithfully mimics
the dimerized state of the WT caspase-9.
We also compared the dimeric caspase-9 to caspase-3
(Figure 3D). The ten Ca atoms on strands b6 and b69 of the
dimeric caspase-9 superimpose very well with the corre-
sponding atoms in caspase-3, exhibiting an overall RMSD of
0.46 A˚ (Figure 3D). The surrounding residues, however, show
significant deviation in both main chain and side chain atoms
(Figure 3D). Structural alignment of the entire dimeric
caspase-9 and caspase-3 results in an RMSD of 1.74 A˚ over
396 Ca atoms.
The Dimeric Caspase-9: More Potent than the Wild Type
Previous structural studies on procaspase-7 demonstrate
that the active site conformation in one monomer exists in an
unproductive conformation until it is supported by the
critical loop L29 from the adjacent monomer [10,11]. This
conclusion is thought to be generally applicable to other
caspases [1]. Therefore, the dimeric caspase-9 is predicted to
exhibit a higher level of catalytic activity than its monomeric
WT counterpart, because the dimeric caspase-9 is poised to
provide the L29 loop. To examine this hypothesis, we
reconstituted an in vitro assay in which the ability of
Figure 2. The Dimeric Caspase-9 Exists as a Monomer in Solution
The apparent molecular masses for the WT and dimeric caspase-9
(full-length, residues 1–416) were analyzed by gel filtration. Relevant
peak fractions were visualized by SDS-PAGE followed by Coomassie
staining. The dimeric caspase-9 was eluted from the column with a
molecular mass about twice that of the WT protein.
DOI: 10.1371/journal.pbio.0030183.g002
Table 1. Analytical Ultracentrifugation Analysis of Caspase-9 Proteins
Sample Molecular Weight (Da) at Rotor Speed (rpm)
8,000 11,000 14,000 Global Molecular
Weight
WT caspase-9 43,700 6 3,550 53,640 6 4,700 50,300 6 2,080 50,550 6 2,550
Dimeric caspase-9 102,620 6 7,080 95,310 6 2,960 89,320 6 2,260 91,030 6 2,100
WT caspase-9 D139 38,260 6 4,480 35,430 6 4,080 36,610 6 4,950 36,450 6 3,300
Dimeric caspase-9 D139 59,060 6 5,100 61,020 6 4,000 61,650 6 2,350 61,490 6 2,350
DOI: 10.1371/journal.pbio.0030183.t001
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caspase-9 to cleave its physiological substrate, procaspase-3
(C163A), was measured in a time-course experiment (Figure
4A). As anticipated, both the full-length and the D139 dimeric
caspase-9 (unpublished data) exhibited a significantly higher
activity than their WT counterparts. To accurately determine
the differences in activity, we repeated these experiments
using the fluorescent substrate specific for caspase-9, LEHD-
AFC (Figure 4B). These results revealed that the full-length
and the D139 dimeric caspase-9 were approximately 2-fold
and 5-fold more active than their WT counterparts, respec-
tively.
Increased catalytic activity for the dimeric caspase-9 is
predicted to correlate with stronger ability in promoting
apoptosis. To test this prediction, the WT and dimeric
caspase-9 were expressed in HeLa and HEK 293 cells; indeed,
the dimeric caspase-9 induced extensive cell death in both
HeLa (Figure 4C) and HEK 293 cells (unpublished data),
whereas overexpression of the WT caspase-9 induced little
apoptosis. The induction and extent of apoptosis were
confirmed by the processing of caspase-3 in cells expressing
the dimeric but not the WT caspase-9 (Figure 4D). Despite its
strong ability in inducing apoptosis, the dimeric caspase-9
was expressed at a much lower level than the WT enzyme
(Figure 4D). This likely reflects the cytotoxic effect of the
dimeric caspase-9 once expressed, or a shorter half-life of the
processed dimeric caspase-9. The activation of caspase-3 and
induction of apoptosis by the dimeric caspase-9 no longer
require the caspase-9-activating factor Apaf-1, because the
dimeric caspase-9 (D139), which lacks the Apaf-1-binding
domain, CARD, was still able to induce efficient cell death
and caspase-3 activation (Figure 4C and 4D). These data
confirm that the dimeric caspase-9 is active in mammalian
cells and that it induces apoptosis by activating caspase-3.
The Dimeric Caspase-9 Is Qualitatively Different from the
Apaf-1-Activated Caspase-9
If induced proximity, interpreted as dimerization-driven
activation of caspases [23], models the correct mechanism for
the activation of caspase-9, then the dimeric caspase-9 should
exhibit a similar level of catalytic activity to the apoptosome-
activated caspase-9. To examine this scenario, we reconsti-
tuted an apoptosome-activated caspase-9 assay using an Apaf-
1 fragment (residues 1–570) that was known to activate
caspase-9 in a cytochrome c-independent manner [16,24,25].
Compared to the dimeric caspase-9, the Apaf-1-activated WT
caspase-9 exhibited an approximately 35-fold higher activity
Figure 3. The Dimeric Caspase-9 Closely Resembles the WT Caspase-9
(A) Overall structure of the dimeric caspase-9 (C287S). The structural
core is shown in blue; the solvent-exposed active site loops are shown
in magenta. The b6 and b69 strands are highlighted in red. Note the
asymmetry of the dimer.
(B) Structural superposition of the dimeric caspase-9 (blue and
magenta) and the WT caspase-9 (grey and green). The only significant
structural difference is in the solvent-exposed active site loops, which
is due to the inactive nature of the dimeric caspase-9 (C287S).
(C) A stereo comparison of the region surrounding strands b6 and b69
in WT and dimeric (engineered) caspase-9. The side chains of the WT
and dimeric caspase-9 are shown in orange and yellow, respectively.
To avoid congestion in the graphic, residues from only one caspase-9
monomer are labeled. The Cys287 in the upper left corner is the
catalytic residue in the active site of the asymmetric caspase-9.
(D) A stereo comparison of the region surrounding strands b6 and b69
in caspase-3 and dimeric (engineered) caspase-9. The side chains of
the caspase-3 and dimeric caspase-9 are shown in green and yellow,
respectively. The labels refer to amino acids in caspase-3.
DOI: 10.1371/journal.pbio.0030183.g003
Table 2. Data Collection and Statistics from Crystallographic
Analysis
Stage Parameter Result
Data collection Space group C2
Resolution (A˚) 99.0–2.8
Total observations 108,559
Unique observations 31,920
Data redundancy (-fold) 3.5
Data coverage (outer shell) 99.0% (98.4%)
Rsym (outer shell) 0.105 (0.367)
Refinement Resolution range (A˚) 20.0–2.8
Number of reflections (jFj . 0) 31,084
Data coverage 96.4%
Rworking/Rfree 23.7% / 28.6%
Number of atoms 7,821
Number of waters 137
RMSD bond length (A˚) 0.008
RMSD bond angles (degree) 1.405
Ramachandran plot Most favored 84.0%
Additionally allowed 14.6%
Generously allowed 1.4%
Disallowed 0%
Rsym =
P
h
P
i j Ih,i  Ih j /
P
h
P
i Ih,i , where Ih is the mean intensity of the i obervations of symmetry related
reflections of h. R =
P j Fobs Fcalc j /
P
Fobs, where Fobs = FP, and Fcalc is the calculated protein structure factor from
the atomic model (Rfree was calculated with 5% of the reflections). RMSD in bond lengths and angles are the
deviations from ideal values, and the RMSD in B factors is calculated between bonded atoms.
DOI: 10.1371/journal.pbio.0030183.t002
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using LEHD-AFC as the substrate (Figure 5A). We also
confirmed this result by performing a time course experi-
ment (Figure 5B), and obtained the same conclusion using
procaspase-3 (C163A) as the substrate (unpublished data).
These results suggest that the dimerization of caspase-9 may
be qualitatively different from the way in which Apaf-1
activates caspase-9.
Next, we examined whether the dimeric caspase-9 can be
activated by Apaf-1 the same way as the WT caspase-9. Using
procaspase-3 (C163A) as the substrate, the catalytic activity of
the dimeric caspase-9 does not change appreciably in the
presence of increasing amounts of Apaf-1 (Figure 6A, lanes 5–
8). In contrast, the WT caspase-9 was activated by Apaf-1 in a
concentration-dependent manner (Figure 6A, lanes 1–4).
Subsequently, in the presence of Apaf-1, the catalytic activity
of WT caspase-9 significantly exceeded that of the dimeric
caspase-9 (Figure 6B).
Discussion
Although induced proximity through high levels of protein
expression can lead to caspase activation, it remains ques-
tionable whether this is indeed how the initiator caspases are
activated under physiological conditions [12]. In fact, much of
the evidence supporting the induced proximity model can
also be used to argue against it. For example, effector
caspases can be autoactivated through induced proximity
when overexpressed in bacteria; yet in mammalian cells the
endogenous effector caspases are activated by the initiator
caspases. Thus, merely showing the processing of caspases due
to forced oligomerization does not constitute strong support
of the induced proximity model and does not explain how
initiator caspases are activated in cells. More importantly, the
initial proposition of the induced proximity model gives little
or no consideration to the most fundamental aspect of
cellular biochemistry: specificity, the specific protein-protein
interactions that are required for the precise positioning and
activation of the initiator caspases.
It should be noted that the concept of caspase activation is
fundamentally different between the effector and the
initiator caspases. The effector caspases, including the
zymogens, exist as constitutive homodimers in solution. Their
activation requires an interdomain cleavage that facilitates
the formation of a productive active site conformation.
However, for the initiator caspases, activation has a quite
different meaning. For example, the processed caspase-9,
Figure 4. The Dimeric Caspase-9 Exhibits Higher Catalytic Activity and Stronger Cell-Killing Activity than the WT Protein
(A) A time course experiment of caspase-9 activity using procaspase-3 (C163A) as the substrate revealed that the dimeric caspase-9 (residues 1–
416) exhibited an approximately 5-fold higher level of catalytic activity than the monomeric WT caspase-9. The concentrations were: WT and
engineered caspase-9, 0.5 lM; procaspase-3 (C163A), 33 lM.
(B) Comparison of catalytic activity for the WT and dimeric caspase-9 using fluorescent substrate LEHD-AFC. Both the full-length and D139
dimeric caspase-9 displayed higher activities than their WT counterparts.
(C) The dimeric caspase-9 induced apoptosis more effectively than the WT protein. Mammalian expression vector pcDNA3 constructs encoding
WT or dimeric caspase-9 were transfected into HeLa or 293 cells. The extent of cell death induced by each construct was examined.
(D) The dimeric but not the WT caspase-9 promoted the activation of caspase-3. The expression of caspase-9 variants (upper panel) and the
processing of caspase-3 (lower panel) from the cell extracts were detected by antibodies against caspase-9 and -3, respectively. No endogenous
caspase-9 band was visible in the vector-transfected cells at lower exposure.
DOI: 10.1371/journal.pbio.0030183.g004
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similar to the unprocessed procaspase-9, is only marginally
active [26,27]; the primary function of the apoptosome is to
up-regulate caspase-9 activity rather than to facilitate its
autoprocessing [26,28]. In fact, the unprocessed caspase-9 can
be activated to the same level by the apoptosome as the
processed caspase-9 [27]. Thus, the activation of caspase-9 is
reflected by its association with the apoptosome and not by
the interdomain cleavage. It remains to be seen whether
caspase-9 activation represents an isolated example or a
general theme among the initiator caspases.
The reported experimental evidence supporting the initial
induced proximity model employed means to facilitate the
oligomerization of caspases using heterologous domains that
dimerize constitutively or upon binding to ligands [13–15,17].
The design of these experiments allowed caspases to be
brought close to each other via their attached dimerization
domains; however, it was not shown that the caspases
themselves had dimerized via their intrinsic dimerization
interface. The initial induced proximity model was given
greater mechanistic meaning when it was explicitly proposed
that dimerization via the intrinsic dimerization interface of
initiator caspases drives their activation [19]. This improved
interpretation of the induced proximity model impinges
upon specific protein conformation and was perceived as the
dominant model to explain the mechanism of initiator
caspase activation [20,21,23].
To validate this induced proximity model, the activity of
the dimerized caspase, such as caspase-9, must be compared
with that of the apoptosome-activated caspase-9. However, a
WT caspase-9 homodimer cannot be isolated because
caspase-9 exists predominantly as a monomer in solution
[22]. If there is any tendency for the WT caspase-9 to
dimerize, the kinetics must be exceedingly fast, since dimeric
caspase-9 has eluded detection by all biochemical means in
our hands. It should also not noted that, although a stable
caspase-9 homodimer was reported to exist in solution [19],
rigorous effort in several laboratories, including ours, to
reproduce this result have not been successful.
Using protein engineering, we generated a stable caspase-9
homodimer by changing residues exclusively at the dimeriza-
tion interface. It should be noted that our dimeric caspase-9
is different from other heterologous caspase constructs
reported in the literature, in which the caspases were fused
to heterologous dimerization domains [13–17]. Whether the
caspases can dimerize via their intrinsic dimerization inter-
face in those circumstances remains undetermined. In
contrast, our design relies on the assumptions that the
engineered caspase-9 would dimerize via its intrinsic dime-
rization interface and would closely resemble the WT protein
except at the buried dimerization interface. Importantly,
these assumptions have been proved correct by our structural
analysis of the dimeric caspase-9. However, the engineered
dimeric caspase-9 exhibits a catalytic activity that is only a
small fraction of that of the WT caspase-9 activated by Apaf-
1. The discrepancy in activity suggests that dimerization of
caspase-9 may be qualitatively different from the Apaf-1-
mediated activation of caspase-9 and is unlikely to be
responsible for the activation of caspase-9 in cells.
Interestingly, the dimeric caspase-9 exhibits an activity that
is only 2- to 5-fold higher than that of the WT caspase-9 (see
Figure 4B). This observation exactly argues against the
prevailing hypothesis that dimerization drives activation of
caspase-9, because if dimerization of caspase-9 were the
mechanism for its activation, the dimeric caspase-9 should
exhibit a much high level of activity—similar to that of the
apoptosome-activated caspase-9. This analysis is further
supported by our structural observation, which reveals that
the five-residue mutation at the interface of the dimeric
caspase-9 does not result in any significant conformational
changes in the local structure surrounding strands b6 and b69.
If dimerization of caspase-9 is not the major mechanism for
its activation, then how is caspase-9 activated by the
apoptosome? We note that the Apaf-1-mediated apoptosome
has a 7-fold symmetry. The activation of another initiator
caspase, caspase-8, is facilitated by the death-inducing
signaling complex, which involves a homotrimeric (3-fold
symmetry) assembly of the death receptor and other
associated factors. One possibility is that the apoptosome
may directly activate monomeric caspase-9 through modifi-
cation of its active site conformation [8,12]. An alternative
model is that the apoptosome assembles the dimeric caspase-
9 into a higher-order complex, which results in the
modification of the active site conformation for an enhanced
activity [12]. In addition, it is possible that the dimerized
caspase-9 in the context of the apoptosome exhibits a
Figure 5. The Dimeric Caspase-9 Exhibits a Much Lower Activity Than the
Apaf-1-Activated WT Caspase-9
(A) Using fluorescent substrate LEHD-AFC, the catalytic activity of
the Apaf-1-activated WT caspase-9 was approximately 35-fold greater
than that of the dimeric caspase-9.
(B) A time course comparison of the catalytic activities between the
Apaf-1-activated WT caspase-9 and the dimeric caspase-9. WT and
dimeric caspase-9, 0.5 lM; Apaf-1 (residues 1–570), 2 lM; LEHD-AFC,
200 lM.
DOI: 10.1371/journal.pbio.0030183.g005
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perturbed interface relative to the crystallographically
observed interface, which may greatly facilitate the catalytic
activity of caspase-9. Although available data are insufficient
to differentiate among these models, exquisite conforma-
tional change of caspase-9 must be induced upon binding to
the apoptosome [29]. This conformational change, most likely
at the level of active site conformation, is the prerequisite for
the activation of caspase-9. We propose that this induced
conformation model is the mechanism for the activation of
initiator caspases.
The induced conformation model for the activation of
initiator caspases is different from the dimerization-driven
induced proximity model, but these two models may not be
mutually exclusive. In some cases, they emphasize different
aspects, and initiator caspases may exist in several distinct
classes. For example, for some initiator caspases, dimerization
might be sufficient for inducing the correct conformation
needed for its activation. In this case, the two models are in
agreement with each other. However, for caspase-9, dimeri-
zation itself is unlikely to be the sole mechanism of activation.
Finally, regardless of the semantics, the activation of any
initiator caspase must require the formation of a productive
active site conformation.
Materials and Methods
Protein preparation. All constructs were generated using a
standard PCR-based cloning strategy, and the identities of individual
clones were verified through double-stranded plasmid sequencing.
All caspase-9 constructs were expressed from the vector pET-21b in
the Escherichia coli strain BL21(DE3). The protein was purified using a
Ni-NTA (Qiagen, Valencia, California, United States) column, and
further fractionated by anion-exchange (Source-15Q, Pharmacia,
Uppsala, Sweden) and gel-filtration chromatography (Superdex-200,
Pharmacia). Caspase-3 (C163A) and Apaf-1 (1–570) were overex-
pressed and purified as described [22].
Crystallization and data collection. Crystals were grown by the
hanging-drop vapor-diffusion method by mixing dimeric caspase-9
(residues 140–416, C287S) with an equal volume of reservoir solution
containing 100 mM MES (pH 6.0), 5% (w/v) PEG 5000 monomethyl
ether, and 3% tacsimate. Crystals appeared overnight and grew to a
typical size of 0.13 0.53 0.5 mm3 in 3 d. The crystals were in the C2
space group, with the cell parameters a = 144.6 A˚, b = 79.0 A˚, c =
125.9 A˚, and b= 112.5 degrees. There are two complete molecules of
dimeric caspase-9 in each asymmetric unit. Diffraction data were
collected using an R-AXISIV imaging plate detector mounted on a
Rigaku 200HB generator (Rigaku, Tokyo, Japan). For data collection,
crystals were equilibrated in a cryoprotectant buffer containing well
buffer plus 20% glycerol, and were flash frozen in a170 8C nitrogen
stream. All datasets were processed using the software Denzo and
Scalepack [30].
Structure determination of the dimeric caspase-9. The structure
was determined by molecular replacement, using the software AmoRe
[31]. The atomic coordinates of caspase-9 [19] were used for
rotational search against a 153.2 A˚ dataset. The top solutions from
the rotational search were individually used for a subsequent
translational search, which yielded the correct solutions with high
correlation factors. A model was built using the program O [32] and
refined using CNS [33]. The final refined atomic model for the
dimeric caspase-9 contains residues 58–196 and 212–303, and 111
ordered water molecules at 2.6 A˚ resolution. The final refined atomic
model contains residues 140–288 and 335–416 for chains A and C,
and 140–289 and 337–416 for chains B and D, respectively.
Caspase-9 assay. The reaction was performed at 37 8C under the
following buffer conditions: 25 mM HEPES (pH 7.5), 100 mM KCl, 4
mM MgCl2, and 2 mM dithiothreitol (DTT). The substrate (procas-
pase-3 [C163A]) concentration was approximately 33 lM. Caspase-9
variants were diluted to the same concentration (0.3 or 0.5 lM) with
the assay buffer. Reactions were stopped with the addition of an
equivolume of 23 SDS loading buffer and boiled for 3 min. The
samples were size-fractionated by SDS-PAGE, and the results were
visualized by Coomassie staining. The assays using the fluorogenic
substrate Ac-LEHD-AFC were performed under similar conditions,
where the substrate concentration was 200 lM. Reactions were
Figure 6. The Dimeric Caspase-9 Can No Longer Be Activated the Same Way as the WT Caspase-9
(A) Increasing amounts of Apaf-1 (residues 1–570) led to a corresponding increase in the catalytic activity of the WT caspase-9, but had no effect
on the activity of the dimeric caspase-9. WT and dimeric caspase-9, 0.5 lM; procaspase-3 (C163A), 33 lM; Apaf-1, 0.24, 0.6, and 1.2 lM.
(B) A time course of procaspase-3 cleavage by the WT and dimeric caspase-9 in the presence of Apaf-1. WT and dimeric caspase-9, 0.3 lM;
procaspase-3 (C163A), 33 lM; Apaf-1, 0.3 lM.
DOI: 10.1371/journal.pbio.0030183.g006
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stopped by placing the samples on ice. Fluorescence emission at 440
nm was measured using an excitation wavelength of 380 nm.
Analytical ultracentrifugation. Protein samples were prepared in
25 mM HEPES (pH 7.5), 100 mM NaCl, and 0.5 mm DTT. Protein
loading concentrations were all 20 lM except for caspase-9 (D139)
which was studied at 10 lM. All sedimentation equilibrium experi-
ments were carried out at 4 8C using a Beckman Optima XL-A
analytical ultracentrifuge (Beckman Instruments, Fullerton, Califor-
nia, United States) equipped with an An60 Ti rotor and six-channel,
12 mm path length, charcoal-filled Epon centerpieces and quartz
windows. Data were collected at three rotor speeds (8,000, 11,000, and
14,000 rpm) and represent the average of 20 scans using a scan step-
size of 0.001 cm. Partial specific volumes and solution density were
calculated using the Sednterp program (www.bbri.org/RASMB/
rasmb.html). Data were analyzed using the WinNONLIN program
from the Analytical Ultracentrifugation Facility at the University of
Connecticut (Storrs, Connecticut, United States).
Apoptosis assays. The ability of caspase-9 variants to induce
apoptosis was assayed as described earlier [16]. Human HeLa cells or
HEK 293 cells were transfected in 12-well plates (105 cells/well) with
0.3 lg of pEGFP-N1 reporter plasmid (Clontech, Palo Alto,
California, United States) and 1.0 lg of vector, or a construct
encoding WT or dimeric caspase-9 using the LipofectAMINE
(Invitrogen, Carlsbad, California, United States) as per the manu-
facturer’s recommendations. After 24 h of transfection normal and
apoptotic GFP-expressing cells were counted using fluorescence
microscopy. The percentage of apoptotic cells in each experiment
was expressed as the mean percentage of apoptotic cells as a fraction
of the total number of GFP-expressing cells. Apoptosis in the cells
transfected with caspase-9 constructs was further confirmed by
immunoblotting these cellular extracts with antibodies (Cell Signal-
ing Technology, Beverly, Massachusetts, United States) raised against
caspase-3 and caspase-9, respectively. The data represent the average
of four independent experiments.
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